在慢性阻塞性肺病患者中,与焦虑和抑郁相关的因素
Anan S Jarab1,2,3, Walid A AlQerem4, Shrouq R Abu Heshmeh1
1Department of Clinical Pharmacy, Faculty of Pharmacy, University of Science and Technology, Irbid, Jordan.
焦虑和抑郁症在COPD患者中很常见. 诸如性别,疾病严重程度和药物使用等因素显著影响这些疾病,凸显了针对性干预的必要性.
科学领域:
- 肺部医学 肺部医学
- 精神病学是一个精神病学.
- 临床研究 临床研究
背景情况:
- 焦虑和抑郁是慢性阻塞性肺病 (COPD) 患者中普遍存在的并发症.
- 这些心理健康状况可以显著影响疾病管理和患者的结果.
- 了解相关因素对于开发有效的干预措施至关重要.
研究的目的:
- 研究COPD诊断的门诊患者中与焦虑和抑郁相关的因素.
- 确定与这些心理健康状况相关的特定的人口,临床和治疗相关的变量.
主要方法:
- 一项横截面研究对约旦两个主要医院的702名COPD门诊患者进行.
- 医院焦虑和抑郁量表 (HADS) 用于评估焦虑和抑郁程度.
- 统计分析发现了各种因素与焦虑和抑郁的存在之间的显著关联.
主要成果:
- 在焦虑/抑郁和性别,疾病严重程度,长效β抗原体 (LABA) 使用,药物计数,修改的医学研究委员会 (mMRC) 评分和吸入技术之间发现了显著的关联.
- 焦虑也与高收入,城市生活,糖尿病,高血压,长效肌肉抗剂 (LAMA) 使用以及较少的COPD药物有关.
- 抑郁症与心脏病,年龄增加和疾病持续时间延长有关.
结论:
- 在COPD患者中,焦虑和抑郁的高发病率强调了针对性干预的必要性.
- 未来的研究应该专注于多样化的样本和建立因果关系,以完善我们对这些关联的理解.
- 识别这些因素可以指导COPD患者制定更有效的治疗策略.
更多相关视频
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
相关概念视频
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
